The NHL pauses hockey season until after Christmas due to COVID-19 risks
The league will begin its holiday break starting at the end of Tuesday night's games, postponing the five remaining games scheduled for Thursday.
COVID
The riddle of Japan's dramatic drop in COVID numbers
The turnaround came in the wake of a fifth wave of infections that peaked in August. Japan is trying to figure out why its COVID-19 case numbers and fatalities have plummeted.
Schools embrace social and emotional learning to help 'overwhelmed' students
School officials believe that kids can't succeed academically if they are struggling emotionally.
Our 11 most-read global pandemic stories of 2021
From India to Israel to white-tailed deer in Iowa harboring the coronavirus, our top COVID stories of the year reveal the ever-changing nature of the world's health crisis.
Omicron may be less severe in South Africa. That may not be the case for the U.S.
Researchers in South Africa have found that people infected with omicron, on average, are less likely to end up in the hospital. But the variant may act differently here in the U.S.
Sandra Lindsay got the first U.S. COVID jab. Here's her secret to motivate others
Since Lindsay rolled up her sleeve to get vaccinated a year ago, she has devoted herself to motivating others, especially those who are hesitant, to get vaccinated. She shares five persuasive tips.
Omicron spreads uncertainty about holiday travel and dampens recovery for airlines
The rapid emergence of the omicron variant of the coronavirus has many questioning whether they should rethink their holiday travel plans.
A mass COVID grave in Peru has left families bereft — and fighting for reburial
More than 400 people who died of COVID were secretly interred in a mass grave on the outskirts of the city of Iquitos. Families are demanding a proper burial for their loved ones.
A different kind of COVID vaccine is about ready to roll
Protein subunit vaccines work by injecting people with a tiny portion of a virus. In the case of the COVID-19 vaccine, that tiny portion is the spike protein that the coronavirus uses to enter cells.
Pfizer wants the FDA to let 16- and 17- year-olds get a COVID-19 booster shot
Pfizer's CEO says the vaccine maker has asked federal regulators to authorize boosters for 16- and 17-year-olds. Currently, only people 18 and over are eligible for a booster in the U.S.